Abstract
Children with chronic diseases are at risk for low bone mineral density (BMD). There are no studies of BMD in children with congenital heart disease and particularly single ventricle (SV). Children with this defect are often treated with warfarin, suspected to negatively impact BMD in adults. We assessed BMD in patients with SV physiology and compared the BMD of subjects taking warfarin to those who were not. Subjects 5–12 years with SV were included. BMD z scores by dual-energy X-ray absorptiometry of the spine and total body less head (TBLH) were obtained. Calcium intake, activity level, height, and Tanner stage were assessed. Linear regression models and t tests were used to investigate differences between participants and normative data as well as between subjects’ subgroups. Twenty-six subjects were included and 16 took warfarin. Mean BMD z score at the spine was significantly lower than expected at −1.0 ± 0.2 (p < 0.0001), as was the BMD z score for TBLH at −0.8 ± 0.2 (p < 0.0001). Those results remained significant after adjusting for height. Subjects who were on warfarin tended to have lower BMD at both the spine and TBLH than those who were not, with a z score difference of 0.6 ± 0.46 at the spine (p = 0.106) and a difference of 0.4 ± 0.34 at TBLH (p = 0.132). BMD is significantly reduced in children with SV. Warfarin appears to lower BMD but the effect is less conclusive. Continued evaluation is recommended for these patients at risk for reduced bone density. Evaluation of other cardiac patients on warfarin therapy should also be considered.
Similar content being viewed by others
References
Avgeri M, Papadopoulou A, Platokouki H et al (2008) Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy. J Pediatr Hematol Oncol 30:592–597
Bachrach LK, Sills IN (2011) Clinical report-bone densitometry in children and adolescents. Pediatrics 127:189–194
Balling G, Vogt M, Kaemmerer H, Eicken A, Meisner H, Hess J (2000) Intracardiac thrombus formation after the Fontan operation. J Thorac Cardiovasc Surg 119:745–752
Barnes C, Newall F, Ignjatovic V et al (2005) Reduced bone density in children on long-term warfarin. Pediatr Res 57:578–581
Bianchi ML (2007) Osteoporosis in children and adolescents. Bone 41:486–495
Caraballo PJ, Gabriel SE, Castro MR, Atkinson EJ, Melton LJ (1999) Changes in bone density after exposure to oral anticoagulants: a meta-analysis. Osteoporos Int 9:441–448
Cheung YF, Chay GW, Chiu CS, Cheng LC (2005) Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure. Int J Cardiol 102:509–513
Coon PD, Rychik J, Novello RT, Ro PS, Gaynor JW, Spray TL (2001) Thrombus formation after the Fontan operation. Ann Thorac Surg 71:1990–1994
Crocker PR, Bailey DA, Faulkner RA, Kowalski KC, McGrath R (1997) Measuring general levels of physical activity: preliminary evidence for the Physical Activity Questionnaire for Older Children. Med Sci Sports Exerc 29:1344–1349
Cromme-Dijkhuis AH, Hess J, Hahlen K et al (1993) Specific sequelae after Fontan operation at mid- and long-term follow-up. Arrhythmia, liver dysfunction, and coagulation disorders. J Thorac Cardiovasc Surg 106:1126–1132
Day RW, Boyer RS, Tait VF, Ruttenberg HD (1995) Factors associated with stroke following the Fontan procedure. Pediatr Cardiol 16:270–275
Dobell AR, Trusler GA, Smallhorn JF, Williams WG (1986) Atrial thrombi after the Fontan operation. Ann Thorac Surg 42:664–667
du Plessis AJ, Chang AC, Wessel DL et al (1995) Cerebrovascular accidents following the Fontan operation. Pediatr Neurol 12:230–236
d’Udekem Y, Iyengar A, Galati J et al (2014) Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation 130:S32–S38
Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA (1999) Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 69:74–79
Fletcher SE, Case CL, Fyfe DA, Gillette PC (1991) Clinical spectrum of venous thrombi in the Fontan patient. Am J Cardiol 68:1721–1722
Fontan F, Baudet E (1971) Surgical repair of tricuspid atresia. Thorax 26:240–248
Freedom RM, Hamilton R, Yoo SJ et al (2000) The Fontan procedure: analysis of cohorts and late complications. Cardiol Young 10:307–331
Hasan BS, Bendaly EA, Alexy RD, Ebenroth ES, Hurwitz RA, Batra AS (2008) Somatic growth after fontan and mustard palliation. Congenit Heart Dis 3(5):330–335
Jacobs ML, Pourmoghadam KK (2007) Thromboembolism and the role of anticoagulation in the Fontan patient. Pediatr Cardiol 28:457–464
Jacobs ML, Pourmoghadam KK, Geary EM et al (2002) Fontan’s operation: is aspirin enough? Is coumadin too much? Ann Thorac Surg 73:64–68
Jahangiri M, Ross DB, Redington AN, Lincoln C, Shinebourne EA (1994) Thromboembolism after the Fontan procedure and its modifications. Ann Thorac Surg 58:1409–1413 discussion 1413–1414
Knapen MH, Hellemons-Boode BS, Langenberg-Ledeboer M et al (2000) Effect of oral anticoagulant treatment on markers for calcium and bone metabolism. Haemostasis 30:290–297
Ma D, Jones G (2003) The association between bone mineral density, metacarpal morphometry, and upper limb fractures in children: a population-based case-control study. J Clin Endocrinol Metab 88:1486–1491
Mathews K, Bale JF Jr, Clark EB, Marvin WJ Jr, Doty DB (1986) Cerebral infarction complicating Fontan surgery for cyanotic congenital heart disease. Pediatr Cardiol 7:161–166
Monagle P, Karl TR (2002) Thromboembolic problems after the Fontan operation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 5:36–47
Monagle P, Cochrane A et al (2011) A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic Acid as primary thromboprophylaxis for 2 years after the fontan procedure in children. J Am Coll Cardiol 58(6):645–651
Musgrave KO, Giambalvo L, Leclerc HL, Cook RA, Rosen CJ (1989) Validation of a quantitative food frequency questionnaire for rapid assessment of dietary calcium intake. J Am Diet Assoc 89:1484–1488
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795
Ono M, Boethig D, Goerler H, Lange M, Westhoff-Bleck M, Breymann T (2007) Somatic development long after the Fontan operation: factors influencing catch-up growth. J Thorac Cardiovasc Surg 134(5):1199–1206
Rosenthal DN, Friedman AH, Kleinman CS, Kopf GS, Rosenfeld LE, Hellenbrand WE (1995) Thromboembolic complications after Fontan operations. Circulation 92:II287–II293
Seipelt RG, Franke A, Vazquez-Jimenez JF et al (2002) Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches. Ann Thorac Surg 74:556–562
Sokoll LJ, Sadowski JA (1996) Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr 63:566–573
Srinivasan C, Jaquiss RD, Morrow WR, Frazier EA, Martin D, Imamura M, Sachdeva R (2010) Impact of staged palliation on somatic growth in patients with hypoplastic left heart syndrome. Congenit Heart Dis 5(6):546–551
Stafford DW (2005) The vitamin K cycle. J Thromb Haemost 3:1873–1878
Stamm C, Friehs I, Mayer JE Jr et al (2001) Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg 121:28–41
Streif W, Andrew M, Marzinotto V et al (1999) Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood 94(9):3007–3014
Tanner JM (1962) Growth at adolescence, with a general consideration of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity, 2nd edn. Blackwell Scientific Publications, London
Vogt KN, Manlhiot C, Van Arsdell G, Russell JL, Mital S, McCrindle BW (2007) Somatic growth in children with single ventricle physiology impact of physiologic state. J Am Coll Cardiol 50(19):1876–1883
Walker HA, Gatzoulis MA (2005) Prophylactic anticoagulation following the Fontan operation. Heart 91:854–856
Acknowledgments
This work was funded by Suzanne P. Murphy Foundation, Bethesda, MD (Roger Hurwitz, MD, PI) and William Fadel was partially supported by TL1 RR025759, Indianapolis, IN (Anantha Shekhar, PI ).
Conflict of interest
None of the authors had any conflict of interest related to the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bendaly, E.A., DiMeglio, L.A., Fadel, W.F. et al. Bone Density in Children with Single Ventricle Physiology. Pediatr Cardiol 36, 779–785 (2015). https://doi.org/10.1007/s00246-014-1083-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-014-1083-3